Sudarshan Pharma Industries Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sudarshan Pharma Industries Ltd. on BSE

Search Inside the pdf :

Sudarshan Pharma Industries Ltd.

19 Aug 2025

34.11

-1.98%

Annual Report

Annual report for Sudarshan Pharma Industries Ltd. for FY-2025

None

pdf

Sudarshan Pharma Industries Ltd.

18 Aug 2025

34.11

-1.98%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is in reply to the query received from BSE dated 18th August 2025 pertaining to resignation of Mr. Manoj Lodha as Chief Financial Officer of the Company w.e.f. 5th August 2025. Resignation Letter received from Mr. Manoj Lodha submitted herewith.

pdf

Sudarshan Pharma Industries Ltd.

18 Aug 2025

34.11

-1.98%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2025, published in Financial Express and Mumbai Lakshdeep.

pdf

Sudarshan Pharma Industries Ltd.

14 Aug 2025

34.11

-1.98%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

The Board of Directors have at their meeting held today, 14-08-2025, approved to acquire land, building, plant and machinery located at plot no. D-22, IDA-Medchal, Medchal Mandal, Malkajigiri District, Telangana - 501401 for a total sale consideration of Rs.25.50 Crores from Srigen Lifesciences Private Limited.

pdf

Sudarshan Pharma Industries Ltd.

14 Aug 2025

34.11

-1.98%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

With effect from 14-08-2025, Mr. Sachin Mehta, Joint Managing Director has been appointed as the Chief Financial Officer and re-designated as Joint Managing Director & Chief Financial Officer of the Company.

pdf

Sudarshan Pharma Industries Ltd.

14 Aug 2025

34.11

-1.98%

Investor Presentation

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Please find attached the updated Investor Presentation.

pdf

Sudarshan Pharma Industries Ltd.

14 Aug 2025

34.11

-1.98%

Result

Sudarshan Pharma Industries Ltd - 543828 - Financial Results For The Quarter 30-06-2025

BSE India

Please find attached the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2025 along with Auditors'' Limited Review Report.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	146.47	162.43	100.18	-9.8%	46.2%
Operating Profit Qtr	11.04	15.93	2.08	-30.7%	430.8%
Net Profit Qtr	3.96	7.41	-1.21	-46.6%	427.3%
Earning Per Share Adjusted latest Qtr	0.16	0.31	-0.05	-48.4%	420.0%

* Consolidated data

Detailed Results

Sudarshan Pharma Industries Ltd.

12 Aug 2025

34.11

-1.98%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Please find enclosed the Scrutinizer''s Report on the business transacted at the Extraordinary General Meeting of the Company held on Monday, 11th August 2025 through video conferencing / other audio visual means.

pdf

Sudarshan Pharma Industries Ltd.

12 Aug 2025

34.11

-1.98%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Shareholder Meeting / Postal Ballot-Outcome of EGM

BSE India

Please find enclosed the voting results on the business transacted at the Extraordinary General Meeting of the Company held on Monday, 11th August 2025 through video conferencing / other audio visual means.

pdf

Sudarshan Pharma Industries Ltd.

11 Aug 2025

34.11

-1.98%

Board Meeting

Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Meeting Of The Board Of …

BSE India

Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Sudarshan Pharma Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2025. Please note that the Trading Window shall remain closed until the expiry of 48 hours after the declaration of the financial results for the quarter ended 30th June 2025.

pdf